Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Tonmya in Fibromyalgia (BESTFIT-OLE)
NCT02015234Phase 3Completed
- Sponsor
- Tonix Pharmaceuticals
- Start
- Dec 2013
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Tonmya in fibromyalgia (FM), sponsored by Tonix Pharmaceuticals. Started Dec 2013; status: completed.
02
Drugs
Tonmya
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02015234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015234.